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CASE REPORT / OLGU SUNUMU
Morganella morganii in sinonasal region: A rare case report
Sinonazal bölgede Morganella morganii: Nadir bir olgu sunumu
Haşmet Yazıcı1, Sedat Doğan1, İlknur Haberal Can2, Yusuf Baygit3, Alicem Tekin4
ÖZET
Morganella morganii, özellikle immunsupresif, uzun dö-
nem idrar yolu kateteri kullanan kişilerde ölümcül hasta-
lıklara  yol  açabilen  Gram-negatif  fırsatçı  bir  patojendir. 
Sıklıkla üriner sistem enfeksiyonlarına yol açmasına rağ-
men kas-iskelet sistemi, santral sinir sistemi ve cilt enfek-
siyonlarına da sebep olabilmektedir. Sporadik enfeksiyon 
olguları nadir olmakla birlikte AİDS, zehirlenmeler ve yılan 
ısırmaları ile birlikte görülebilmektedir. Sino-kutanöz fistül, 
preseptal selülit ve oro-maksiller fistül gelişimi görülen, 58 
yaşındaki diabetik erkek hastada yapılan tetkikler sonucu 
M morganii enfeksiyonu saptandı. Hastaya fronto-etmoi-
dektomi ve mediyal maksillektomi yapıldı. İki hafta uygu-
lanan medikal tedavi sonucu genel durumu düzeldi. Bu 
olgu,  araştırmalarımıza  göre  sinonazal  bölgede  ilk  kez 
görülen M. morganii enfeksiyonu olup tanı, tedavi ve klinik 
yönleriyle tartışılmıştır.
Anahtar kelimeler: Morganella morganii, sinonazal fistül, 
preseptal selülit, kemik defekti
ABSTRACT
Morganella morganii is a gram negative pathogen and 
may cause potentially lethal disease especially in patients 
with underlying or immunosuppressive disease. It is com-
monly found in long-term urinary catheter used and im-
mune system deficiency patients as nosocomial disease. 
Involving  other  systems  such  as  skin,  skeletal  system 
and central nervous system can be seen too. Sporadic 
occurrence is rare and can be seen in any system by vari-
ous causes like AIDS, snake bites and poisoning. In this 
case we present sporadic Morganella morganii infection 
on sinonasal region with the presence of sinusitis, sino-
cutaneous fistula, preseptal cellulitis and hard palate de-
fect on 58 year old male diabetic patient. Microbiological 
assessment from open wound and sinuses were reported 
as Morganella morganii. To our knowledge, this is the first 
case of sino-nasal Morganella morganii infection with si-
no-cutaneous fistula, preseptal cellulitis and maxillofacial 
bone destruction. J Clin Exp Invest 2013; 4 (3): 383-386
Key words: Morganella Morganii, sino-nasal fistula, pre-
septal cellulitis, bone destruction
INTRODUCTION
Morganella morganii is a member of Proteae which 
is  included  in  Enterobacteriaceae  family  [1].  M. 
morganii is a Gram-negative opportunistic bacillus 
which is usually found in the environment and in the 
intestinal tracts of humans, mammals, and reptiles 
as normal flora. It has two subgroups named mor-
ganii and sibonii. They can cause wound infections, 
urinary infections usually on patient who have uro-
lithiasis, pneumonia, skeletal infections and central 
nervous  system disease  [2-4]. Appropriate  antibi-
otic therapy is important for the best treatment of 
the disease. Usually they are naturally resistant to 
many beta-lactam antibiotics and may be resistant 
to ceftazidime and other third generation cephalo-
sporins, but they are susceptible to cefepime, imi-
penem, meropenem, piperacillin, aminoglycosides, 
and  fluoroquinolones.  Improper  antibiotic  therapy 
may lead to delay on diagnosis and it is a predis-
posing factor for infection process. In uncomplicat-
ed cases mono therapy is usually enough. Combi-
nation therapy with two antibiotics (based on sus-
ceptibility of organism) is preferred for complicated 
cases and immune compromised patients. Surgical 
therapy is indicated for treating underlying disease.
CASE
A fifty eight-year-old male diabetic patient attended 
ear-nose-throat  clinic  with  complaints  of  purulent 
drainage, hyperemia and swelling on the right side Yazıcı et al. M. morganii in sinonasal region 384
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of face (Figure 1). Patient had received ten days 
of  amoxicillin-clavulanic  acid  therapy.  Leukocyto-
sis  and  hyperglycemia  were  detected  on  labora-
tory investigation. Dark colored granulation tissue 
was  seen  with  anterior  rhinoscopy.  On  CT  scan 
there were mucosal thicknesses on right maxillary, 
ethmoid, sphenoid and frontal sinuses (Figure 2). 
Furthermore erosive abscess formation with a size 
of 3x1.5 cm on periorbital area and inflammatory 
thickness on optic nerve and retro-orbital fat tissue 
were detected. There was no intracranial involve-
ment.  Endoscopic  sinus  surgery  was  performed. 
Right middle concha was necrotic and adhered to 
septum. Nasal cavity was full of dark colored gran-
ulation tissue and lamina papyracea was eroded. 
There were fistulas at the base of maxillary sinus 
opening into oral cavity and at the anterior part of 
maxillary sinus. Fronto-maxilla-ethmoidectomy and 
medial maxillectomy were performed. All granula-
tion tissue was removed and send for microbiologi-
cal assessment.
Figure 1. Patient’s picture
In microbiology laboratory, the granulation tis-
sue specimen was inoculated onto 5% sheep blood 
agar and Eosin-Methylen Blue agar (EMB) (Merck 
KGaA, Darmstadt, Germany) media plates. Then, 
these media plates were aerobically incubated at 
35 ± 2°C for 18-24 hours. Identification of Gram-
negative isolate was performed by using conven-
tional methods. Antimicrobial susceptibility testing 
of isolate was determined by measuring the diam-
eter of inhibition zone around the antibiotic discs 
with using the Kirby-Bauer’s disc diffusion method 
according to the Clinical and Laboratory Standards 
Institute  susceptibility  interpretive  breakpoints  [5]. 
Escherichia coli ATCC 25922 reference strain was 
used for the quality control of antimicrobial suscepti-
bility testing. M. morganii was observed on cultures 
taken from granulation tissue.
Meticulous insulin therapy for regulation of di-
abetes and I.V. meronem 3x1 gr, amikacin 1x1 gr 
for 15 days, amphotericin B 1x50 mg were started. 
Fistulizated  wound  was  healed  by  daily  surgical 
debridement  and  dressing  with  riphocin  and  acid 
borique  solution.  After  two  week  sino-cutaneous 
fistula healed. Preseptal cellulite and sinusitis re-
gressed and general condition of patient improved. 
However diabetic control couldn’t be obtained and 
patient was referred to endocrine service. During 
follow  up  period  patient’s  blood  glucose  control 
couldn’t be obtained and after 13 days patient died 
from sepsis.
DISCUSSION
Morganella is a Gram-negative opportunistic bacil-
lus which is a member of Enterobacteriaceae fam-
ily [1]. In 1906, Morgan described a non-lactose-
fermenting organism as a different pathogen while 
studying the etiology of summer infantile diarrhea 
[6]. After then, in 1919 Winslow named this patho-
gen as Bacillus morganii for the production of indole 
and the fermentation of carbonhydrates and non-
ability of liquefaction of gelatin [7]. For a long time, 
Morganella was known as a type of Proteus and 
called as Proteus morganii. In 1978 Brenner et al. 
and in 1985 Farmer et al. showed that Morganella is 
a different organism from Proteus [8]. Identification 
of M. morganii is made by recovery of small, oxi-
dase-negative, catalase and indole positive Gram-
negative rod on 5% sheep blood agar or EMB agar. 
M. morganii ferments glucose and mannose but not 
lactose. M. morganii is motile, facultative anaerobic 
and non-encapsulated, and it hydrolyzes urea and 
reduces nitrates.
Immunosuppressive  treatment,  poison  con-
tamination, history of surgery, advanced age, uro-
lithiasis, improper antibiotic therapy and AIDS are 
the risk factors for M. morganii infections [9]. Most 
common clinical presentations are wound infection 
and urinary tract infection [2]. Furthermore M. mor-
ganii can cause perinatal infections, late-onset neo-
natal infections, fatal necrotizing fasciitis, skeletal 
infections  and  central  nervous  system  infections 
[3,4]. In this case, presence of DM and improper 
antibiotic therapy were the risk factors that we found 
for M. morganii infection. There were sinusitis and 
bone defects at anterior, inferior part of maxilla and 
lamina papyracea. In the literature, no bone defect 
caused by Morganella infection was reported in si-
nonasal region.Yazıcı et al. M. morganii in sinonasal region 385
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Figure 2. Preoperative Computed Tomography image
Treatment  should  be  done  by  medically  and 
surgically if needed. First of all, due to the opportu-
nistic character of M. morganii, underlying disease 
must  be  treated.  Uncomplicated  and  early  diag-
nosed infections can be treated with mono antibiotic 
therapy. Choice of antibiotic treatment is very im-
portant because improper antibiotic therapy is a risk 
factor for development of M. morganii infection [9]. 
Naturally M. morganii is resistant to penicillin, ampi-
cillin, ampicillin-sulbactam, oxacillin, first and sec-
ond-generation cephalosporins, by chromosomally 
encoded  AmpC  beta-lactamases  and  possesses 
the ability to develop resistance upon exposure to 
broad-spectrum cephalosporins [10]. Most strains 
are  naturally  susceptible  to  piperacillin,  ticarcillin, 
mezlocillin,  third-  and  fourth-generation  cephalo-
sporins,  carbapenems,  aztreonam,  fluoroquino-
lones,  aminoglycosides,  and  chloramphenicol.  In 
case of abscess formation, cutaneous open wound 
or concurrent disease (chronic sinusitis, sino-cuten-
ous fistula and abscess formation on periorbicular 
tissue) surgery should be done.
In conclusion, M. morganii is a rare opportunis-
tic pathogen which could cause serious diseases. 
This infection must be treated with multidisciplinary 
approach. To our knowledge this is the first case in 
sinonasal region with uncommon features of this in-
fection like bone destruction, sino-cutaneous fistula 
and preseptal cellulitis.
REFERENCES
1.  O’Hara  CM,  Brenner  FW,  Miller  JM.  Classification, 
identification  and  clinical  significance  of Proteus, 
Providencia  and Morganella.  Clin  Microbiol  Rev 
2000;13:534-546.
2. Tucci V, Isenberg HD. Hospital cluster epidemic with 
Morganella morganii.  J  Clin  Microbiol  1981;14:563-
566.
3. Jorge MT, Ribeiro LA, da Silva ML, et al. Microbio-
logical  studies  of  abscesses  complicating  Bothrops 
snakebite  in  humans:  a  prospective  study.  Toxicon 
1994;32:743-748.
4. Abdalla J, Saad M, Samnani I, et al. Central nervous 
system infection caused by Morganella morganii. Am 
J Med Sci 2006;331:44-47.
5.  Clinical  and  Laboratory  Standards  Institute.  Perfor-
mance standards for antimicrobial susceptibility test-
ing; Twenty-second Informational Supplement. Docu-
ment M100-S22. Wayne, PA 2012.
6. Morgan H de R. Report XCV. Upon the bacteriology of 
the summer diarrhea of infants. Br Med J 1906;1:908-
912.Yazıcı et al. M. morganii in sinonasal region 386
J Clin Exp Invest   www.jceionline.org   Vol 4, No 3, September 2013
7. Winslow CEA, Kligler IJ, Rothberg W. Studies on the 
classification of the colon-typhoid group of bacteria 
with special reference to their fermentative reactions. 
J Bacteriol 1919;4:429-503.
8. Brenner DJ, Farmer JJ III, Fanning GR, et al. Deoxyri-
bonucleic acid relatedness of Proteus and Providen-
cia species. Int J Syst Bacteriol 1978;28:269-282.
9.  McDermott  C,  Mylotte  JM.  Morganella  morganii: 
epidemiology  of  bacteremic  disease.  Infect  Control 
1984;5:131-137.
10. Biedenbach DJ, Jones RN, Erwin ME. Interpretive ac-
curacy of the disk diffusion method for testing newer 
orally administered cephalosporins against Morgan-
ella morganii. J Clin Microbiol 1993;31:2828-2830.